|
1.
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Gramantieri L, Ferracin M, Fornari F, et
al: Cyclin G1 is a target of miR-122a, a microRNA frequently
downregulated in human hepatocellular carcinoma. Cancer Res.
67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Murakami Y, Yasuda T, Saigo K, et al:
Comprehensive analysis of microRNA expression patterns in
hepatocellular carcinoma and non-tumorous tissues. Oncogene.
25:2537–2745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Budhu A, Jia HL, Forgues M, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Shah YM, Morimura K, Yang Q, Tanabe T,
Takagi M and Gonzalez FJ: Peroxisome proliferator-activated
receptor alpha regulates a microRNA-mediated signaling cascade
responsible for hepatocellular proliferation. Mol Cell Biol.
27:4238–4247. 2007. View Article : Google Scholar
|
|
9.
|
Huang YS, Dai Y, Yu XF, et al: Microarray
analysis of microRNA expression in hepatocellular carcinoma and
non-tumorous tissues without viral hepatitis. J Gastroenterol
Hepatol. 23:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Jiang J, Gusev Y, Aderca I, et al:
Association of microRNA expression in hepatocellular carcinomas
with hepatitis, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Varnholt H, Drebber U, Schulze F, et al:
MicroRNA gene expression profile of hepatitis C virus-associated
hepatocellular carcinoma. Hepatology. 47:1223–1232. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ladeiro Y, Couchy G, Balabaud C, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor-suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yang L, Ma Z, Wang D, Zhao W, Chen L and
Wang G: MicroRNA-602 regulating tumor suppressive gene RASSF1A is
overexpressed in hepatitis B virus-infected liver and
hepatocellular carcinoma. Cancer Biol Ther. 9:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Li HP, Leu YW and Chang YS: Epigenetic
changes in virus-associated human cancers. Cell Res. 15:262–271.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Park IY, Sohn BH, Yu E, et al: Aberrant
epigenetic modifications in hepatocarcinogenesis induced by
hepatitis B virus X protein. Gastroenterology. 132:1476–1494. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tong A, Gou L, Lau QC, et al: Proteomic
profiling identifies aberrant epigenetic modifications induced by
hepatitis B virus X protein. J Proteome Res. 8:1037–1046. 2009.
View Article : Google Scholar
|
|
17.
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Fabbri M, Garzon R, Cimmino A, et al:
MicroRNA-29 family reverts aberrant methylation in lung cancer by
targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA.
104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce C: MicroRNA expression and function in cancer. Trends Mol
Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kutay H, Bai S, Datta J, et al:
Downregulation of miR-122 in the rodent and human hepatocellular
carcinomas. J Cell Biochem. 99:671–678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Jacob JR, Sterczer A, Toshkov IA, et al:
Integration of woodchuck hepatitis and N-myc rearrangement
determine size and histologic grade of hepatic tumors. Hepatology.
39:1008–1016. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Harada H, Nagai H, Ezura Y, et al:
Down-regulation of a novel gene, DRLM, in human liver malignancy
from 4q22 that encodes a NAP-like protein. Gene. 296:171–177. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Wong QW, Lung RW, Law PT, et al:
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and
potentiates expression of Stathmin1. Gastroenterology. 135:257–269.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Oh BK, Kim H, Park HJ, et al: DNA
methyltransferase expression and DNA methylation in human
hepatocellular carcinoma and their clinicopathological correlation.
Int J Mol Med. 20:65–73. 2007.PubMed/NCBI
|
|
25.
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Danenberg PV and Laird PW: CpG island hypermethylation in human
colorectal tumors is not associated with DNA methyltransferase
over-expression. Cancer Res. 59:2302–2306. 1999.PubMed/NCBI
|
|
26.
|
Ding WJ, Fang JY, Chen XY and Peng YS: The
expression and clinical significance of DNA methyltransferase
proteins in human gastric cancer. Dig Dis Sci. 53:2083–2089. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Fang JY, Cheng ZH, Chen YX, et al:
Expression of DNMT1, demethylase, MeCP2 and methylation of
tumor-related genes in human gastric cancer. World J Gastroenterol.
10:3394–3398. 2004.PubMed/NCBI
|
|
28.
|
Wang YA, Kamarova Y, Shen KC, et al: DNA
methyltransferase-3a interacts with p53 and represses p53-mediated
gene expression. Cancer Biol Ther. 4:1138–1143. 2005. View Article : Google Scholar : PubMed/NCBI
|
